{
  "company": {
    "name": "Nyra Medical, Inc.",
    "website": "https://nyramedical.com/",
    "record": "https://startuphistory.org/c/nyramedical.com"
  },
  "status": null,
  "history_since": "2025-05-16T02:38:41.000Z",
  "baseline": {
    "snapshot_id": "cfbdc5f39822ed3a340e786f5d3608ecce78d9f364370a2c37f5ddf5a24d20e0",
    "observed_at": "2025-05-16T02:38:41.000Z",
    "headline": "Rewriting the Rules of Mitral Valve Repair",
    "description": "Redefining mitral valve repair with CARLEN — a single-leaflet solution expanding options for TEER-eligible and previously untreatable patients.",
    "evidence": "https://web.archive.org/web/20250516023841/https://nyramedical.com/",
    "evidence_kind": "internet_archive",
    "facts": {
      "version": 1,
      "pages": [
        {
          "page": "home",
          "customers": [],
          "investors": [],
          "prices": [],
          "compliance": [],
          "funding": [
            "licensed its core technology, CARLEN, in 2021 and raised Series A in 2022 supported by experienced medtech investors."
          ]
        }
      ]
    },
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:51:04.010Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-06T17:51:04.010Z",
      "variants": [
        {
          "headline": "Rewriting the Rules of Mitral Valve Repair",
          "subhead": "Redefining mitral valve repair with CARLEN — a single-leaflet solution expanding options for TEER-eligible and previously untreatable patients.",
          "observed_at": "2025-05-16T02:38:41.000Z",
          "evidence": "https://web.archive.org/web/20250516023841/https://nyramedical.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Rewriting the Rules of Mitral Valve Repair",
          "subhead": "Redefining mitral valve repair with CARLEN — a single-leaflet solution expanding options for TEER-eligible and previously untreatable patients.",
          "observed_at": "2025-07-12T13:44:29.000Z",
          "evidence": "https://web.archive.org/web/20250712134429/https://nyramedical.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Rewriting the Rules of Mitral Valve Repair",
          "subhead": "Redefining mitral valve repair with CARLEN — a single-leaflet solution expanding options for TEER-eligible and previously untreatable patients.",
          "observed_at": "2026-01-18T02:15:46.000Z",
          "evidence": "https://web.archive.org/web/20260118021546/https://nyramedical.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Rewriting the Rules of Mitral Valve Repair",
          "subhead": "Redefining mitral valve repair with CARLEN — a single-leaflet solution expanding options for TEER-eligible and previously untreatable patients.",
          "observed_at": "2026-07-12T20:27:10.000Z",
          "evidence": "https://web.archive.org/web/20260712202710/https://nyramedical.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Rewriting the Rules of Mitral Valve Repair",
          "subhead": "Redefining mitral valve repair with CARLEN — a single-leaflet solution expanding options for TEER-eligible and previously untreatable patients.",
          "observed_at": "2026-11-06T17:51:04.010Z",
          "evidence": "https://nyramedical.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Rewriting the Rules of Mitral Valve Repair",
      "subhead": "Redefining mitral valve repair with CARLEN — a single-leaflet solution expanding options for TEER-eligible and previously untreatable patients.",
      "from": "2025-05-16T02:38:41.000Z",
      "to": "2026-11-06T17:51:04.010Z",
      "captures": 5,
      "evidence": "https://nyramedical.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2025-05-16T02:38:41.000Z",
          "to": "2026-11-06T17:51:04.010Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-059f3d6aca8c6e031fcb5edcf33c3bf537297df77e7670ff0833234d42876eb5:a1f3ddf283af696ac8887b3ef41fd02043a58eaf9bbd47b14226e6b404241371:funding:baf4f0f1f7028eef",
      "before_evidence": "https://web.archive.org/web/20260712202710/https://nyramedical.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “licensed its core technology, CARLEN, in 2021 and raised Series A in 2022 supported by experienced medtech investors.”.",
      "between": {
        "from": "2026-07-12T20:27:10.000Z",
        "to": "2026-11-06T17:51:04.010Z"
      },
      "evidence": "https://nyramedical.com/",
      "evidence_kind": "live_capture",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Nyra Medical, Inc.” company record, https://startuphistory.org/c/nyramedical.com"
}